J&J Innovative Medicine Europe, Middle East & Africa (EMEA) dans l'actualité
Développement de solutions médicamenteuses innovantes
Tamtam a trouvé 20 articles récents sur J&J Innovative Medicine Europe, Middle East & Africa (EMEA).
- Focused on developing medicines for some of the world’s most complex and devastating diseases
- When Europe Treats Healthcare Innovation as a Cost, Patients Pay the Price
- Harnessing Europe’s Data Potential: How HONEUR Can Help Improve Patient Outcomes
- ICOTYDE™ (icotrokinra) one-year results demonstrate lasting skin clearance and favourable safety profile in once-daily tablet for plaque psoriasis
- European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor
- Leading where medicine is going
- Laetitia Decroix Guilloux Elevated as President at Johnson & Johnson Innovative Medicine, Canada
- Johnson & Johnson’s approach to pricing
- Immunology | J&J Innovative Medicine EMEA
- Partnerships | J&J Innovative Medicine
- J&J’s Tremfya secures marketing authorisation from EC for UC
- J&J’s Martin Price on World Cancer Day 2025 – Part 2
- SC formulation of Rybrevant-Leclaza combo therapy endorsed for approval in Europe
- A haunting short film from Johnson & Johnson is reframing depression
- Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting
- J&J clinches EC approval for first single-pill PAH combo
- Why a disclosure of transfer of value code?
- Data Science – Data and AI are revolutionizing healthcare
- Ins & Outs: J&J, BioMarin, and Telix announce leadership changes
- Scaling innovation to tackle Europe’s growing mental health crisis
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme J&J Innovative Medicine Europe, Middle East & Africa (EMEA) ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires